Navigation Links
UK Based Machinery Manufacturer, SEPHA, Thrives Despite Downturn
Date:1/23/2010

The private equity backed manufacturing firm, Sepha, has bucked the economic downturn with a 33% increase in sales for 2009. Sepha Ltd which is based in Northern Ireland, manufactures innovative non-destructive leak testing, deblistering and lab-scale blister packing machines for the pharmaceutical industry. Much of its growth has come from export markets, particularly the low labour cost economies of India, Asia and South America.

(Vocus) January 21, 2010 -- A UK manufacturing company has bucked the economic downturn with an increase in sales of 33% in 2009*. Sepha Ltd which is based in Northern Ireland, manufactures innovative non-destructive leak testing, deblistering and lab-scale blister packing machines for the pharmaceutical industry. Much of its growth has come from export markets, particularly the low labour cost economies of India, Asia and South America. Sepha’s Chief Executive, Aubrey Sayers, explains “Markets such as India and China offer a lower manufacturing cost base for western pharma companies, but when it comes to pharmaceuticals, the emphasis must still be on production quality. Sepha’s machines offer an automated way of checking the quality of drug packaging which further saves on production costs.”

Within western economies Sepha has also been able to take advantage of the drive by its customers to reduce waste and disposal costs. Sepha’s innovative machines safely remove valuable product from defective packs, allowing them to be repackaged and sold on to the customer. In addition its range of leak testing machines, which are used to detect holes in pharmaceutical blister packs, sachets and pouches, offer a clean, non-destructive alternative to the widely used and messy methylene blue dye leak test which results in unnecessary waste of valuable product, whether the packaging is defective or not.

Sepha is already doing business with many of the world’s top pharmaceutical manufacturers including Boots, Bayer and Wyeth. It has been designing and building machines in Northern Ireland since 1980. A number of internal factors including a focused investment in international sales and marketing and an increase in production capacity combined with the cost saving nature of its machines have allowed Sepha to achieve this growth in adverse market conditions.

###

Read the full story at http://www.prweb.com/releases/Sepha/leaktest/prweb3484744.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. New DNA-based technique for assembly of nano- and micro-sized particles
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense
6. BioNanomatrix Receives New NCI Grant to Support Development of Chip-Based Nanofluidics Systems for Cell Fractionation
7. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
8. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
9. Coherent Announces Restatement Related to Stock-Based Compensation
10. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
11. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UK Based Machinery Manufacturer, SEPHA, Thrives Despite Downturn
(Date:4/20/2017)... ... April 20, 2017 , ... ... new webinar will explore challenging patient cases when screening for direct oral anticoagulant. ... may be a need for bridging parental anticoagulation especially for those at high ...
(Date:4/20/2017)... Maine (PRWEB) , ... April 20, 2017 , ... ... contributions to the scientific and clinical research community’s growing body of knowledge during ... 2017 in the Gracie Theatre and the adjacent Darling Atrium. During the event, ...
(Date:4/20/2017)... ... , ... Parallel6™ , the leader in mClinical™ technologies for improving patient ... one of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma ... “We take pride in honoring Parallel6 as one of the top 10 companies that ...
(Date:4/20/2017)... YORK , April 20, 2017 ... that focuses on novel drug development and clinical research aimed ... are: Biostage Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), ... ZIOP ). You can access our complimentary research ... ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 15.1% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):